`

Sigilon Therapeutics

Biotechnology Research

Specialities :
Cell therapy
Biotechnology
Hemophilia
Diabetes
Lysosomal storage disorders

+3

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$144.9M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Sigilon Therapeutics

What does Sigilon therapeutics do?+

Sigilon Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. Were based in Cambridge, Mass

What are Sigilon therapeutics's specialties? +

Cell therapy,biotechnology,hemophilia,diabetes,lysosomal storage disorders,biocompatible materials,chronic diseases,and cell engineering

What is Sigilon therapeutics's industry? +

Sigilon therapeutics operates in the Biotechnology research industry.

What is Sigilon therapeutics's revenue? +

Sigilon therapeutics's revenue is 11m - 100m

What is Sigilon therapeutics's company size? +

Sigilon therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free